ArriVent BioPharma, Inc. Common Stock(AVBP)

$24.25▲0.03 (10.32%)

ArriVent BioPharma, Inc. Common Stock(AVBP)

NASDAQ

$24.25▲0.03 (10.32%)

Overview Intelligence Chart Fundamentals Key Metrics Earnings Growth Analysts Financials Insiders Institutional

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

6 analysts·Limited coverage

100%

Rating Distribution

Strong Buy

00%

Buy

6100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 81% higher.

Bear Case

$43.00

+77%

Consensus

$44.00

+81%

Bull Case

$45.00

+86%

Price Range6 analysts

Low

Consensus

High

$43.00

$45.00

Current Target

Current Price

$24.25

Upside to Target

$19.75

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+28649.92%

EPS—

FY2028

Rev+264.41%

EPS—

FY2029

Rev+103.71%

EPS—

Earnings Surprises

Recent Analyst Actions

Dec 10, 2025BTIG

ArriVent Biopharma initiated with a Buy at BTIG on firmonertinib potential

Target:$45.00

+80.7%from $24.91

Nov 25, 2025Truist Financial

ArriVent Biopharma initiated with a Buy at Truist

Target:$43.00

+99.9%from $21.51

Jul 10, 2025Goldman Sachs

ArriVent Biopharma resumed with a Buy at Goldman Sachs

Target:$33.00

+49.8%from $22.03

Sep 10, 2024Citigroup

ArriVent BioPharma (AVBP) PT Raised to $36 at Citi

Target:$36.00

+28.9%from $27.93

Sep 10, 2024H.C. Wainwright

ArriVent BioPharma (AVBP) PT Raised to $36 at H.C. Wainwright

Target:$36.00

+28.4%from $28.04

Aug 16, 2024H.C. Wainwright

ArriVent BioPharma (AVBP) PT Raised to $30 at H.C. Wainwright

Target:$30.00

+27.0%from $23.62

Jul 22, 2024Oppenheimer

Oppenheimer Starts ArriVent BioPharma (AVBP) at Outperform

Target:$35.00

+86.5%from $18.77

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance